Y. Lozynskyy

Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis

M. Vieth, M. Stolte, I. Cascorbi, 2010, Inflammatory bowel diseases.